Our team of experienced drug developers and company builders partner with a new generation of passionate, business-minded scientists to foster each therapeutic program from discovery through clinical trials.

board members

Charles Homcy

Richard Scheller

Ali Satvat

James Momtazee

Neil Kumar


company

Adam Shaywitz

Agis Kydonieus

Ai Li

Alan Ji

Ali Satvat

Alix Alderman

Amy Thompson

Ananth Sridhar

Andrea Orozco

Andreas Betz

Angelos Dovletoglou

Anjali Pandey

Anna Maciag

Anna Wade

April Yang

Asha Rajagopal

Ashley Cooper

Athiwat Hutchaleelaha

Baird Ruch

Becky Dabora

Ben Neel

Benjamin Collman

Brian Eater

Brian Metcalf

Brian Stephenson

Bruno Gagnon

Cameron Turtle

Carina Castilla

Carl Dambkowski

Carolina Brekke

Chao Cui

Charles Homcy

Christine Siu

Christopher Brown

Christopher Foo

Chuck Nomides

Chun Jiang

Clayton Beard

Corey Woolfolk

Craig Berman

Curtis Scribner

Dan Gretler

Dan Hoth

Daniel Genov

Daniel Mulreany

Daniela Rogoff

Danny Joh

David Hinds

David Martin

David Nader

David Rintell

David Scott

David Smith

David Turner

Dawn Hill

Dawn Toronto

Dennis Adair

Donna Cabral-Lilly

Doris Davis

Dwight Nissley

Elizabeth Vadas

Eric Chen

Eric David

Eric Gomez

Ervin Epstein

Evangeline de Guzman

Franco Valle

Frank McCormick

Frank Rockhold

Fred Porter

Fred Reno

Gang Li

Gary Mansfield

George Koshy

Gerd Kochendoerfer

Hannah Shen

Hans Goldberg

Hao Chen

Harris Soifer

Hector Rodriguez

Hernan Fuentes

Holly Condon

Holly Maxfield

Holly Prentice

Hoyoung Huh

Hua Deng

Isabella Graef

Jacki Fontaine

James Andrew Whitney

James Kanter

James Momtazee

Jean Tang

Jeanette Lisac

Jenelle Lin

Jennifer Bond

Jeremy Rouse

Jesper Jernelius

Jessica Meidinger

Jonathan Barr

Jonathan Fox

partners

investors

This page links to Internet sites operated and maintained by entities other than BridgeBio and its affiliates. BridgeBio is not responsible for the content available on any third-party Internet sites linked to this website. BridgeBio provides these links as a convenience to users, but such links do not imply BridgeBio’s endorsement of material on any linked third-party site.

BridgeBio is committed to developing leaders as well as drugs. We are looking for individuals whose passion for creating life-changing medicines will inspire hands-on engagement and the dogged pursuit of novel solutions in the face of adversity.

Join Us